RIGEL PHARMACEUTICALS INC's ticker is RIGL and the CUSIP is 766559603. A total of 104 filers reported holding RIGEL PHARMACEUTICALS INC in Q2 2014. The put-call ratio across all filers is 0.31 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2016 | $460,000 | -32.1% | 221,308 | 0.0% | 0.00% | 0.0% |
| Q4 2015 | $677,000 | +26.5% | 221,308 | +2.3% | 0.00% | 0.0% |
| Q3 2015 | $535,000 | -37.4% | 216,390 | -18.7% | 0.00% | 0.0% |
| Q2 2015 | $854,000 | +36.4% | 266,009 | +51.8% | 0.00% | 0.0% |
| Q1 2015 | $626,000 | +28.3% | 175,200 | -18.9% | 0.00% | 0.0% |
| Q4 2014 | $488,000 | +46.1% | 215,934 | +25.5% | 0.00% | 0.0% |
| Q3 2014 | $334,000 | -24.8% | 172,034 | +26.1% | 0.00% | 0.0% |
| Q2 2014 | $444,000 | -30.4% | 136,434 | -31.0% | 0.00% | 0.0% |
| Q1 2014 | $638,000 | -10.0% | 197,691 | -14.5% | 0.00% | 0.0% |
| Q4 2013 | $709,000 | +34.3% | 231,300 | +56.6% | 0.00% | 0.0% |
| Q3 2013 | $528,000 | +143.3% | 147,727 | +126.5% | 0.00% | – |
| Q2 2013 | $217,000 | – | 65,222 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CM Management, LLC | 1,500,000 | $1,620,000 | 1.72% |
| Soleus Capital Management, L.P. | 14,803,015 | $15,987,256 | 1.48% |
| ARMISTICE CAPITAL, LLC | 17,136,000 | $18,506,880 | 0.28% |
| SPHERA FUNDS MANAGEMENT LTD. | 1,228,126 | $1,326,376 | 0.24% |
| GSA CAPITAL PARTNERS LLP | 971,441 | $1,049 | 0.09% |
| NJ State Employees Deferred Compensation Plan | 200,000 | $216,000 | 0.03% |
| Providence Wealth Advisors, LLC | 27,500 | $29,013 | 0.03% |
| OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) | 1,151,765 | $1,243,906 | 0.03% |
| XTX Topco Ltd | 164,238 | $177,377 | 0.03% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 3,369,076 | $3,638,602 | 0.02% |